Primum, an innovative healthcare technology company focused on supporting community oncologists in delivering high-quality cancer care, has announced the appointment of Erica Conroy, Ph.D., as CEO and Co-Founder. With an impressive background in healthcare technology and drug development, Erica is well-prepared to drive Primum’s mission to transform cancer care from its headquarters in Ohio.
Erica brings a deep passion for cancer treatment and a lifelong commitment to advancing science and technology to enhance patient care. Before joining Primum, she was Senior Vice President of Partnerships at AndHealth, where she helped secure early investments totaling $57 million and expanded care access for over 100,000 patients. Prior to her role at AndHealth, Erica served as Senior Vice President of Product, playing a crucial role in the successful acquisition of CoverMyMeds by McKesson in 2017 for $1.4 billion. In this position, she led the development and rapid scaling of billion-dollar products and businesses.
As the leader of Primum, Erica and her team are committed to keeping community oncologists informed about the latest and most effective cancer treatments. Primum facilitates real-time peer-to-peer consultations between community oncologists and specialized oncologists from major academic centers through its online portal and mobile app. These “curbside consults” allow community oncologists to receive expert feedback within an average of two hours, enabling them to quickly apply this guidance to their patient care.
“As someone who began my scientific career at Ohio State, I’m thrilled to establish Columbus as Primum’s headquarters,” said Erica Conroy, CEO and Co-Founder of Primum. “With cancer treatments evolving at an unprecedented pace, it’s crucial that we provide oncologists with faster, more efficient ways to share information. Primum is free for oncologists, and provides them an easy-to-use platform to connect with leading experts nationwide.”
“We are thrilled to welcome Erica Conroy as the new CEO of Primum,” said Parker Hayden, Head of Portfolio Management at Redesign. “Her leadership, along with a proven track record of success in healthcare technology product, sales, and operations, is paired with a deep personal passion to support the advancement of oncology. Primum’s ability to connect oncologists nationwide with experts has resulted in treatment changes 57% of the time, making this an incredibly meaningful community for oncologists. We believe Primum will transform oncologists’ access to the latest scientific advancements, especially in underserved areas, to improve patient outcomes.”
“This is a capability every oncologist needs, and with Primum, they don’t have to be limited to their immediate networks,” said Dr. Lee Schwartzberg, Section Chief of Medical Oncology at the William N. Pennington Cancer Institute at Renown. “It’s great to be able to connect with oncologists across the country with whom I would not otherwise have been able to interact. The breadth of oncologists and their various questions about real-world, often complex clinical situations allows me to share my experience and expertise quickly and easily.”
“As an oncologist, having access to Primum’s platform allows me to consult with top experts on difficult cases without delays, ensuring my patients receive the most informed care decisions while staying in our community,” said Dr. Neel Trivedi, Medical Oncologist at Nazareth Hospital. “It’s a game-changer for community cancer care.”
Primum is actively inviting oncologists across the U.S. to join the platform, which is designed to integrate seamlessly into their clinical workflow. Whether addressing complex patient cases or collaborating on the latest treatments, Primum provides oncologists with a powerful new tool to deliver optimal care while ensuring that patients remain in their communities.
